Evidence map›Paper›PMID 24881994›Full record

Trial reportLancet (London, England)2014

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people.

Eleni Rapsomaniki, Adam Timmis, Julie George, Mar Pujades-Rodriguez, Anoop D Shah, Spiros Denaxas, Ian R White, Mark J Caulfield, John E Deanfield, Liam Smeeth and 3 more

2 registry-linked trialsOpen access · hybridAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Lancet (London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 817 papers, 23 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
817citing papers in PubMed, 23 pooled it
61.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01164371 completednot on this map

Gender Differences in the Development and Prognosis of Coronary Disease Where Initial Disease Manifestation is Stable Angina, Myocardial Infarction or Unheralded Coronary Death: A CALIBER Study Using Linked GPRD-MINAP Data

TypeobservationalSponsorUniversity College, LondonRan2010 to 2013Enrolled1,758,584ConditionsCoronary Disease, Cardiovascular Disease
NCT04515095 nacompletednot on this mapstarted 2020, after this paper: background citation

A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients

TypeinterventionalSponsorTrueNorth Health FoundationRan2020 to 2022Enrolled30ConditionsHypertensionArmsWater-only Fasting
3 · Its place in the literature

Who cites it

817 citing papers in PubMed, 23 syntheses or guidelines pooled it, 1,613 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Guideline
  8. Guideline
  9. Pooled it
  10. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  11. Pooled it
  12. Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  13. Pooled it
  14. Guideline
  15. Pooled it
  16. Evening versus morning dosing regimen drug therapy for hypertension.The Cochrane database of systematic reviews · 2024
    Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

757 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Eleni RapsomanikiThe Farr Institute of Health Informatics Research, London, UK; Epidemiology and Public Health, University College London, London, UK. Electronic address: e.rapsomaniki@ucl.ac.uk.
Adam TimmisThe Farr Institute of Health Informatics Research, London, UK; Barts and The London National Institute for Health Research Cardiovascular Biomedical Research Unit, Queen Mary University of London, London, UK.
Julie GeorgeThe Farr Institute of Health Informatics Research, London, UK; Epidemiology and Public Health, University College London, London, UK.
Mar Pujades-RodriguezThe Farr Institute of Health Informatics Research, London, UK; Epidemiology and Public Health, University College London, London, UK.
Anoop D ShahThe Farr Institute of Health Informatics Research, London, UK; Epidemiology and Public Health, University College London, London, UK.
Spiros DenaxasThe Farr Institute of Health Informatics Research, London, UK; Epidemiology and Public Health, University College London, London, UK.
Ian R WhiteMRC Biostatistics Unit, Cambridge, UK.
Mark J CaulfieldThe Farr Institute of Health Informatics Research, London, UK; William Harvey Research Institute and the Barts National Institute for Health Research Biomedical Research Unit, Queen Mary University of London, London, UK.
John E DeanfieldThe Farr Institute of Health Informatics Research, London, UK; National Centre for Cardiovascular Prevention and Outcomes, Institute of Cardiovascular Science, University College London, London, UK.
Liam SmeethThe Farr Institute of Health Informatics Research, London, UK; Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Bryan WilliamsThe Farr Institute of Health Informatics Research, London, UK; University College London and National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, UK.
Aroon HingoraniThe Farr Institute of Health Informatics Research, London, UK; Epidemiology and Public Health, University College London, London, UK.
Harry HemingwayThe Farr Institute of Health Informatics Research, London, UK; Epidemiology and Public Health, University College London, London, UK.
University College London · GBFarr Institute · GBMRC Biostatistics Unit · GBWilliam Harvey Research Institute · GB

Funding

Arthritis Research UKBritish Heart FoundationCancer Research UKChief Scientist OfficeDepartment of Health DRF-2009-02-50Department of Health RP-PG-0407-10314Medical Research Council G0902393Medical Research Council G0902393/99558Medical Research Council G9521010Medical Research Council MC_PC_13090Medical Research Council MC_U105260558Medical Research Council MR/K006584/1Medical Research Council U10526055Medical Research Council U105260558Wellcome Trust 086091/Z/08/ZWellcome Trust 093830Wellcome Trust 0938/30/Z/10/ZWellcome Trust 098504Wellcome Trust MR/K006584/1
6 · The paper itself

Abstract

backgroundThe associations of blood pressure with the different manifestations of incident cardiovascular disease in a contemporary population have not been compared. In this study, we aimed to analyse the associations of blood pressure with 12 different presentations of cardiovascular disease.

methodsWe used linked electronic health records from 1997 to 2010 in the CALIBER (CArdiovascular research using LInked Bespoke studies and Electronic health Records) programme to assemble a cohort of 1·25 million patients, 30 years of age or older and initially free from cardiovascular disease, a fifth of whom received blood pressure-lowering treatments. We studied the heterogeneity in the age-specific associations of clinically measured blood pressure with 12 acute and chronic cardiovascular diseases, and estimated the lifetime risks (up to 95 years of age) and cardiovascular disease-free life-years lost adjusted for other risk factors at index ages 30, 60, and 80 years. This study is registered at ClinicalTrials.gov, number NCT01164371.

findingsDuring 5·2 years median follow-up, we recorded 83,098 initial cardiovascular disease presentations. In each age group, the lowest risk for cardiovascular disease was in people with systolic blood pressure of 90-114 mm Hg and diastolic blood pressure of 60-74 mm Hg, with no evidence of a J-shaped increased risk at lower blood pressures. The effect of high blood pressure varied by cardiovascular disease endpoint, from strongly positive to no effect. Associations with high systolic blood pressure were strongest for intracerebral haemorrhage (hazard ratio 1·44 [95% CI 1·32-1·58]), subarachnoid haemorrhage (1·43 [1·25-1·63]), and stable angina (1·41 [1·36-1·46]), and weakest for abdominal aortic aneurysm (1·08 [1·00-1·17]). Compared with diastolic blood pressure, raised systolic blood pressure had a greater effect on angina, myocardial infarction, and peripheral arterial disease, whereas raised diastolic blood pressure had a greater effect on abdominal aortic aneurysm than did raised systolic pressure. Pulse pressure associations were inverse for abdominal aortic aneurysm (HR per 10 mm Hg 0·91 [95% CI 0·86-0·98]) and strongest for peripheral arterial disease (1·23 [1·20-1·27]). People with hypertension (blood pressure ≥140/90 mm Hg or those receiving blood pressure-lowering drugs) had a lifetime risk of overall cardiovascular disease at 30 years of age of 63·3% (95% CI 62·9-63·8) compared with 46·1% (45·5-46·8) for those with normal blood pressure, and developed cardiovascular disease 5·0 years earlier (95% CI 4·8-5·2). Stable and unstable angina accounted for most (43%) of the cardiovascular disease-free years of life lost associated with hypertension from index age 30 years, whereas heart failure and stable angina accounted for the largest proportion (19% each) of years of life lost from index age 80 years.

interpretationThe widely held assumptions that blood pressure has strong associations with the occurrence of all cardiovascular diseases across a wide age range, and that diastolic and systolic associations are concordant, are not supported by the findings of this high-resolution study. Despite modern treatments, the lifetime burden of hypertension is substantial. These findings emphasise the need for new blood pressure-lowering strategies, and will help to inform the design of randomised trials to assess them.

fundingMedical Research Council, National Institute for Health Research, and Wellcome Trust.

Indexed as

Acute DiseaseAdultAgedAged, 80 and overAge DistributionAngina PectorisAntihypertensive AgentsAortic Aneurysm, AbdominalBlood PressureCardiovascular DiseasesChronic DiseaseEnglandFemaleFollow-Up StudiesHumansHypertensionAntihypertensive Agents

Identifiers

PMID24881994
PMCPMC4042017
OpenAlexW2169428949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.